Stay updated with breaking news from Nasdaq Alks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $1.34-$1.57 for the period, compared to the consensus earnings per share estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Analysts Set […]
Alkermes plc (NASDAQ:ALKS – Get Rating) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $32.34 and last traded at $32.01, with a volume of 302433 shares traded. The stock had previously closed at $31.93. Wall Street Analysts Forecast Growth Several brokerages have recently issued reports […]
Alkermes (NASDAQ:ALKS – Get Rating) had its price objective hoisted by Mizuho from $36.00 to $40.00 in a research report released on Wednesday, The Fly reports. ALKS has been the subject of a number of other research reports. Stifel Nicolaus boosted their price target on shares of Alkermes to $30.00 in a research note on […]
Alkermes plc (NASDAQ:ALKS – Get Rating) Director Cato T. Laurencin sold 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $31.50, for a total value of $88,200.00. Following the transaction, the director now owns 7,479 shares of the company’s stock, […]
In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer. Watch this video to hear grantees’ perspectives about the impact of AIG.